Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

Part of Cannabis and your health

The University of New Brunswick has appointed Canada’s first academic research chair in cannabis health, The Globe and Mail has learned.

Yang Qu, a plant biochemist currently at Brock University in St. Catharines, Ont., will begin the new position in January. The tenure-track job will be split between the departments of chemistry and chemical engineering and is thought to be the first of its kind in the world.

Dr. Qu’s appointment, which comes more than a year after the cannabis chair was announced, is an important step for UNB, which aspires to be a global leader in cannabis research and is laying the groundwork to make cannabis-related studies and courses a new academic pillar at the Fredericton-based institution.

Story continues below advertisement

“The industry is crying out for some really strong, bona fide research efforts because much of the evidence [on cannabis] has been anecdotal,” said David MaGee, vice-president of research at UNB. “This allows us to get in on the ground … and help develop research in a number of different areas.”

Although his most recent work has been on anti-cancer drugs, Dr. Qu says his primary interest in cannabis involves discoveries that will help the industry grow. The key to that, he believes, is looking into the untapped medicinal potential of cannabinoids, the chemical compounds in cannabis that affect brain receptors. While cannabis plants have more than 100 cannabinoids, little is known about most of them.

The research produced to date has concentrated mostly on two cannabinoids: tetrahydrocannabinol (THC), which is responsible for giving users a high, and cannabidiol (CBD), which is commonly associated with pain relief and decreased anxiety.

Guy Chamberland, the CEO and chief science officer of Tetra Bio-Pharma, which is funding a portion of the chair along with the New Brunswick Health Research Foundation, says university research is critical to destigmatizing cannabis.

“Our universities have to generate the data to convince physicians and other stakeholders that it can be part of health care,” he said. “Unfortunately people just remember the negative aspects of getting high and not that this could be a medication.”

In addition to discovering more about cannabinoids, Dr. Qu said he is interested in “developing new production strategies for cannabinoids,” including figuring out whether they can be produced in a lab rather than growing an actual plant. If he is able to develop a methodology, it could alleviate the pinch licensed producers feel when the demand for products spikes but the supply is restricted by the slow production cycle.

Dr. Qu also said he believes the genetics of cannabis plants can be improved for greenhouse production and for growing in cold climates.

Story continues below advertisement

He has already begun talks with some of UNB’s industry partners. The school recently signed several memorandums of understanding amid a broader effort to transform New Brunswick into a cannabis industry-friendly hub.

One of those memorandums is with Canada House Wellness Group Inc., a licensed cannabis producer in talks with the university to develop cannabis-related curricula for professional courses that could lead to certificate or degree programs.

St. Thomas University, also based in Fredericton, remains on the hunt for a candidate to fill its cannabis research chair, which will have a social science focus, likely on policy development.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies